CN103071006A - 一种治疗肾功能衰竭中药的制备方法及质量检测方法 - Google Patents
一种治疗肾功能衰竭中药的制备方法及质量检测方法 Download PDFInfo
- Publication number
- CN103071006A CN103071006A CN2013100495777A CN201310049577A CN103071006A CN 103071006 A CN103071006 A CN 103071006A CN 2013100495777 A CN2013100495777 A CN 2013100495777A CN 201310049577 A CN201310049577 A CN 201310049577A CN 103071006 A CN103071006 A CN 103071006A
- Authority
- CN
- China
- Prior art keywords
- solution
- radix
- preparation
- reference substance
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 68
- 239000003814 drug Substances 0.000 title claims abstract description 42
- 238000000034 method Methods 0.000 title claims abstract description 27
- 208000001647 Renal Insufficiency Diseases 0.000 title claims abstract description 13
- 201000006370 kidney failure Diseases 0.000 title claims abstract description 13
- 238000007689 inspection Methods 0.000 title claims abstract description 5
- 239000008187 granular material Substances 0.000 claims abstract description 39
- 239000000843 powder Substances 0.000 claims abstract description 27
- 238000000605 extraction Methods 0.000 claims abstract description 21
- VKJGBAJNNALVAV-UHFFFAOYSA-M Berberine chloride (TN) Chemical compound [Cl-].C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 VKJGBAJNNALVAV-UHFFFAOYSA-M 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 153
- 239000000243 solution Substances 0.000 claims description 117
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 71
- 238000012360 testing method Methods 0.000 claims description 63
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 57
- 239000013558 reference substance Substances 0.000 claims description 45
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 44
- 239000000706 filtrate Substances 0.000 claims description 33
- 239000000047 product Substances 0.000 claims description 29
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 27
- 229960004756 ethanol Drugs 0.000 claims description 26
- 239000000284 extract Substances 0.000 claims description 25
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 21
- 239000000463 material Substances 0.000 claims description 19
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 18
- 238000004809 thin layer chromatography Methods 0.000 claims description 17
- 239000000741 silica gel Substances 0.000 claims description 15
- 229910002027 silica gel Inorganic materials 0.000 claims description 15
- 239000002904 solvent Substances 0.000 claims description 15
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 12
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 12
- 238000010992 reflux Methods 0.000 claims description 12
- 239000012567 medical material Substances 0.000 claims description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 9
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
- 239000000796 flavoring agent Substances 0.000 claims description 9
- 235000019634 flavors Nutrition 0.000 claims description 9
- 239000007921 spray Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 239000004375 Dextrin Substances 0.000 claims description 7
- 229920001353 Dextrin Polymers 0.000 claims description 7
- 241000628997 Flos Species 0.000 claims description 7
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 7
- 235000019425 dextrin Nutrition 0.000 claims description 7
- IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 claims description 6
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 229910021529 ammonia Inorganic materials 0.000 claims description 6
- 238000003556 assay Methods 0.000 claims description 6
- 239000011230 binding agent Substances 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 6
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 6
- 235000019253 formic acid Nutrition 0.000 claims description 6
- 238000004811 liquid chromatography Methods 0.000 claims description 6
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 6
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical group O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 5
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000010282 Emodin Substances 0.000 claims description 4
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 claims description 4
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 claims description 4
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 claims description 4
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 claims description 4
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 claims description 4
- 206010013786 Dry skin Diseases 0.000 claims description 3
- 229910021578 Iron(III) chloride Inorganic materials 0.000 claims description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 3
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 229940126678 chinese medicines Drugs 0.000 claims description 3
- 238000004587 chromatography analysis Methods 0.000 claims description 3
- 238000007796 conventional method Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 239000013078 crystal Substances 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 claims description 3
- 229930182470 glycoside Natural products 0.000 claims description 3
- 150000002338 glycosides Chemical class 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 230000007062 hydrolysis Effects 0.000 claims description 3
- 238000006460 hydrolysis reaction Methods 0.000 claims description 3
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 3
- 239000006210 lotion Substances 0.000 claims description 3
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 3
- 239000003208 petroleum Substances 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 238000000079 presaturation Methods 0.000 claims description 3
- 229960003371 protocatechualdehyde Drugs 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- 239000012047 saturated solution Substances 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 239000012085 test solution Substances 0.000 claims description 3
- 239000009961 Shenshuaining Substances 0.000 abstract description 23
- 240000004980 Rheum officinale Species 0.000 abstract description 6
- 235000008081 Rheum officinale Nutrition 0.000 abstract description 6
- 238000013461 design Methods 0.000 abstract description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 238000004128 high performance liquid chromatography Methods 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 description 19
- 230000000694 effects Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 6
- 238000009413 insulation Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 241000219061 Rheum Species 0.000 description 4
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 3
- 150000004056 anthraquinones Chemical class 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 238000003809 water extraction Methods 0.000 description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 208000020832 chronic kidney disease Diseases 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 229940126534 drug product Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 201000003126 Anuria Diseases 0.000 description 1
- 241000219321 Caryophyllaceae Species 0.000 description 1
- 102000001189 Cyclic Peptides Human genes 0.000 description 1
- 108010069514 Cyclic Peptides Proteins 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241000205407 Polygonum Species 0.000 description 1
- 241001038562 Pseudostellaria heterophylla Species 0.000 description 1
- 240000001745 Rheum palmatum Species 0.000 description 1
- 235000008090 Rheum palmatum Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 208000026775 severe diarrhea Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000009603 uroscopy Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
序号 | 参 数 | 实施例1 | 实施例2 | 实施例3 | 实施例4 | 实施例5 |
1 | 太子参 | 250克 | 200克 | 225克 | 300克 | 275克 |
2 | 大黄 | 650克 | 600克 | 700克 | 550克 | 500克 |
3 | 黄连 | 90克 | 120克 | 80克 | 110克 | 100克 |
4 | 茯苓 | 200克 | 180克 | 150克 | 225克 | 250克 |
5 | 法半夏 | 200克 | 300克 | 275克 | 225克 | 250克 |
6 | 丹参 | 650克 | 700克 | 600克 | 800克 | 750克 |
7 | 陈皮 | 110克 | 90克 | 120克 | 80克 | 100克 |
8 | 红花 | 120克 | 100克 | 110克 | 80克 | 90克 |
9 | 牛膝 | 225克 | 250克 | 200克 | 170克 | 150克 |
10 | 甘草 | 90克 | 110克 | 120克 | 80克 | 100克 |
11 | 大黄浸泡加温 | 58℃ | 55℃ | 60℃ | 63℃ | 65℃ |
12 | 大黄浸泡保温 | 40小时 | 44小时 | 42小时 | 48小时 | 45小时 |
13 | 大黄提取温度 | 80℃ | 82℃ | 84℃ | 81℃ | 85℃ |
14 | 太子参浸泡加温 | 58℃ | 60℃ | 65℃ | 63℃ | 55℃ |
15 | 太子参浸泡保温 | 53小时 | 72小时 | 48小时 | 60小时 | 66小时 |
16 | 太子参提取温度 | 84小时 | 80小时 | 85小时 | 82小时 | 83小时 |
17 | 糊精8-10%, | 245克 | 265克 | 206克 | 236克 | 218克 |
18 | 甜菊素15-25g | 18克 | 25克 | 20克 | 22克 | 15克 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310049577.7A CN103071006B (zh) | 2013-02-07 | 2013-02-07 | 一种治疗肾功能衰竭中药的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310049577.7A CN103071006B (zh) | 2013-02-07 | 2013-02-07 | 一种治疗肾功能衰竭中药的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103071006A true CN103071006A (zh) | 2013-05-01 |
CN103071006B CN103071006B (zh) | 2014-10-22 |
Family
ID=48147851
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310049577.7A Active CN103071006B (zh) | 2013-02-07 | 2013-02-07 | 一种治疗肾功能衰竭中药的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103071006B (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104758515A (zh) * | 2015-04-08 | 2015-07-08 | 云南理想药业有限公司 | 一种治疗肾病的中药组合物及其制备方法和检测方法 |
CN105079574A (zh) * | 2015-09-22 | 2015-11-25 | 启东市春江通风设备厂(普通合伙) | 一种治疗肾功能衰竭的膏方 |
CN105486790A (zh) * | 2015-11-18 | 2016-04-13 | 山西德元堂药业有限公司 | 肾衰宁颗粒的指纹图谱检测方法 |
CN106198823A (zh) * | 2016-08-24 | 2016-12-07 | 秦皇岛市山海关药业有限责任公司 | 一种肾衰宁片有效成分的测定方法 |
CN107961364A (zh) * | 2017-12-06 | 2018-04-27 | 南方医科大学深圳医院 | 一种治疗慢性肾衰竭的中药组合物 |
CN108841550A (zh) * | 2018-09-19 | 2018-11-20 | 福建农林大学 | 一种太子参配制黄酒的加工方法 |
CN113030365A (zh) * | 2021-03-10 | 2021-06-25 | 贵州百灵企业集团制药股份有限公司 | 一种主治实热火毒,三焦热盛之证的中药制剂及检测方法 |
CN113125627A (zh) * | 2020-01-16 | 2021-07-16 | 云南雷允上理想药业有限公司 | 一种治疗肾病的中药组合物的有效成分检测方法 |
CN114636760A (zh) * | 2020-12-15 | 2022-06-17 | 云南雷允上理想药业有限公司 | 一种治疗肾脏疾病的中药组合物的指纹图谱建立方法及其应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101584786A (zh) * | 2009-07-11 | 2009-11-25 | 刘秀英 | 一种治疗慢性肾功能不全的中药制剂 |
CN101816715A (zh) * | 2009-11-24 | 2010-09-01 | 云南理想药业有限公司 | 使用hplc法测定肾衰宁胶囊中丹参素含量的方法 |
CN102488806A (zh) * | 2011-12-23 | 2012-06-13 | 云南理想药业有限公司 | 一种肾衰宁中药制剂及其制备方法 |
CN102488805A (zh) * | 2011-12-23 | 2012-06-13 | 云南理想药业有限公司 | 一种用高分子絮凝沉淀技术制备肾衰宁制剂的方法 |
-
2013
- 2013-02-07 CN CN201310049577.7A patent/CN103071006B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101584786A (zh) * | 2009-07-11 | 2009-11-25 | 刘秀英 | 一种治疗慢性肾功能不全的中药制剂 |
CN101816715A (zh) * | 2009-11-24 | 2010-09-01 | 云南理想药业有限公司 | 使用hplc法测定肾衰宁胶囊中丹参素含量的方法 |
CN102488806A (zh) * | 2011-12-23 | 2012-06-13 | 云南理想药业有限公司 | 一种肾衰宁中药制剂及其制备方法 |
CN102488805A (zh) * | 2011-12-23 | 2012-06-13 | 云南理想药业有限公司 | 一种用高分子絮凝沉淀技术制备肾衰宁制剂的方法 |
Non-Patent Citations (1)
Title |
---|
药典委员会: "《中国药典一部》", 31 January 2010 * |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104758515A (zh) * | 2015-04-08 | 2015-07-08 | 云南理想药业有限公司 | 一种治疗肾病的中药组合物及其制备方法和检测方法 |
CN105079574A (zh) * | 2015-09-22 | 2015-11-25 | 启东市春江通风设备厂(普通合伙) | 一种治疗肾功能衰竭的膏方 |
CN105486790A (zh) * | 2015-11-18 | 2016-04-13 | 山西德元堂药业有限公司 | 肾衰宁颗粒的指纹图谱检测方法 |
CN106198823A (zh) * | 2016-08-24 | 2016-12-07 | 秦皇岛市山海关药业有限责任公司 | 一种肾衰宁片有效成分的测定方法 |
CN106198823B (zh) * | 2016-08-24 | 2018-06-26 | 秦皇岛市山海关药业有限责任公司 | 一种肾衰宁片有效成分的测定方法 |
CN107961364B (zh) * | 2017-12-06 | 2021-01-26 | 南方医科大学深圳医院 | 一种治疗慢性肾衰竭的中药组合物 |
CN107961364A (zh) * | 2017-12-06 | 2018-04-27 | 南方医科大学深圳医院 | 一种治疗慢性肾衰竭的中药组合物 |
CN108841550A (zh) * | 2018-09-19 | 2018-11-20 | 福建农林大学 | 一种太子参配制黄酒的加工方法 |
CN113125627A (zh) * | 2020-01-16 | 2021-07-16 | 云南雷允上理想药业有限公司 | 一种治疗肾病的中药组合物的有效成分检测方法 |
CN113125627B (zh) * | 2020-01-16 | 2022-10-18 | 云南雷允上理想药业有限公司 | 一种治疗肾病的中药组合物的有效成分检测方法 |
CN114636760A (zh) * | 2020-12-15 | 2022-06-17 | 云南雷允上理想药业有限公司 | 一种治疗肾脏疾病的中药组合物的指纹图谱建立方法及其应用 |
CN114636760B (zh) * | 2020-12-15 | 2024-01-02 | 云南雷允上理想药业有限公司 | 一种治疗肾脏疾病的中药组合物的指纹图谱建立方法及其应用 |
CN113030365A (zh) * | 2021-03-10 | 2021-06-25 | 贵州百灵企业集团制药股份有限公司 | 一种主治实热火毒,三焦热盛之证的中药制剂及检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103071006B (zh) | 2014-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103071006B (zh) | 一种治疗肾功能衰竭中药的制备方法 | |
CN103330758A (zh) | 一种芍药甘草汤配方颗粒及其制备方法和检测方法 | |
CN106727806B (zh) | 一种三七叶总皂苷的制备方法 | |
CN102091168A (zh) | 一种中药制剂血府逐瘀胶囊的质量控制方法 | |
CN109528803A (zh) | 一种太子参提取物的制备方法及其制备的太子参提取物和检测方法 | |
CN101040999B (zh) | 一种治疗打鼾的药物组合物及制备方法和检测方法 | |
CN102353735B (zh) | 通脉糖眼明胶囊的质量检测方法 | |
CN106620610A (zh) | 一种甘草泻心颗粒的制备方法 | |
CN107102093B (zh) | 复方丹茵膏的检测方法 | |
CN1969958A (zh) | 一种治疗病毒性肝炎的口服制剂的质量控制方法 | |
CN102920964B (zh) | 一种治疗咳嗽的中药制剂 | |
CN104257768A (zh) | 各种成分比例稳定均一的大黄总蒽醌及其组合物用于治疗胰腺炎 | |
CN104127471A (zh) | 一种金银花配方颗粒的制备方法及其质量控制方法 | |
CN101428130A (zh) | 一种治疗胰腺炎的中药制剂及其制备方法和质量标准 | |
CN100391504C (zh) | 一种治疗性功能障碍的药物组合物及其制备方法 | |
CN115317588A (zh) | 保元汤、保元浸膏、保元固体制剂的制备方法 | |
CN101732406A (zh) | 板蓝清热颗粒的质量检测方法 | |
CN103055191A (zh) | 一种治疗肾炎引起血尿的中药的制备方法及质量检测方法 | |
CN104224951A (zh) | 各种成分比例稳定均一的大黄总蒽醌及其组合物用于治疗胆囊炎 | |
CN102940724A (zh) | 一种用于消炎的中药复方胶囊的制备方法 | |
CN109521122B (zh) | 一种治疗功能性消化不良的中药制剂的指纹图谱的制备方法 | |
CN113030364A (zh) | 一种三黄颗粒的检测方法 | |
CN109394806B (zh) | 人参玉竹的加工方法 | |
CN107014945B (zh) | 一种治疗急性传染性肝炎的中药制剂的检测方法 | |
CN104147140A (zh) | 一种秦皮配方颗粒的制备方法及其质量控制方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 650503 Kunming new town high tech industrial base, Hing Street, No. 39, Yunnan Patentee after: YUNNAN LEIYUNSHANG LIXIANG PHARMACEUTICAL CO.,LTD. Address before: 650000 Kunming Province, Kunming national hi tech Development Zone, No., Kam Road, No. 139 Patentee before: YUNNAN LIXIANG PHARMACEUTICAL Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: No. 39 Huanxing Street, High tech Industrial Base, Kunming New City, Yunnan Province, 650503 Patentee after: Yunnan Leiyunshang Pharmaceutical Co.,Ltd. Country or region after: China Address before: No. 39 Huanxing Street, High tech Industrial Base, Kunming New City, Yunnan Province, 650503 Patentee before: YUNNAN LEIYUNSHANG LIXIANG PHARMACEUTICAL CO.,LTD. Country or region before: China |
|
CP03 | Change of name, title or address |